Literature DB >> 19862686

Muscarinic receptor blockade in the ventral tegmental area attenuates cocaine enhancement of laterodorsal tegmentum stimulation-evoked accumbens dopamine efflux in the mouse.

Deranda B Lester1, Anthony D Miller, Charles D Blaha.   

Abstract

The reinforcing properties of cocaine have been related to increased extracellular concentrations of dopamine in the nucleus accumbens (NAc). M5 muscarinic acetylcholine receptors (mAChRs) on dopamine cells in the ventral tegmental area (VTA) facilitate mesoaccumbens dopamine transmission and are critically involved in mediating natural and drug reinforcement. We investigated the effects of pharmacological blockade of mAChRs in the VTA on cocaine's ability to enhance electrically evoked NAc dopamine efflux. Using fixed potential amperometry together with carbon fiber recording microelectrodes positioned in the NAc core, we quantified dopamine oxidation currents (dopamine efflux) evoked by brief stimulation (15 monophasic pulses at 50 Hz every 30 s) of the laterodorsal tegmentum (LDT) in urethane (1.5 g/kg, i.p.) anesthetized mice. Compared to predrug baseline responses, cocaine (5 or 10 mg/kg, i.p.) dose-dependently enhanced LDT stimulation-evoked NAc dopamine efflux, whereas the nonsubtype selective mAChR antagonist scopolamine (10 microg/0.5 microl) microinfused into the VTA diminished LDT-evoked NAc dopamine efflux. Preinfusion of scopolamine into the VTA diminished the facilitatory actions of cocaine on LDT stimulation-evoked NAc dopamine efflux, and when infused at the peak effect of cocaine attenuated LDT-evoked dopamine efflux to below predrug baseline levels. These findings suggest that LDT cholinergic inputs to dopamine neurons in the VTA, via activation of mAChRs (probably of the M5 subtype), are involved in modulating the facilitatory effects of cocaine on NAc dopamine neurotransmission. They also suggest that the development of antagonists aimed at selectively disrupting M5 receptor function may be valuable in reducing abuse liability of psychostimulants. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19862686     DOI: 10.1002/syn.20717

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  12 in total

1.  Intra-ventral tegmental area microinjections of urotensin II modulate the effects of cocaine.

Authors:  L E Mueller; M A Kausch; T Markovic; D A A MacLaren; D M Dietz; J Park; S D Clark
Journal:  Behav Brain Res       Date:  2014-10-01       Impact factor: 3.332

Review 2.  Structural and functional considerations of the cholinergic brainstem.

Authors:  Juan Mena-Segovia
Journal:  J Neural Transm (Vienna)       Date:  2016-03-05       Impact factor: 3.575

3.  Contribution of both M1 and M4 receptors to muscarinic agonist-mediated attenuation of the cocaine discriminative stimulus in mice.

Authors:  Morgane Thomsen; Craig W Lindsley; P Jeffrey Conn; Jeffrey E Wessell; Brian S Fulton; Jürgen Wess; S Barak Caine
Journal:  Psychopharmacology (Berl)       Date:  2011-10-01       Impact factor: 4.530

4.  Genotype-dependent effects of adolescent nicotine exposure on dopamine functional dynamics in the nucleus accumbens shell in male and female mice: a potential mechanism underlying the gateway effect of nicotine.

Authors:  Price E Dickson; Tiffany D Rogers; Deranda B Lester; Mellessa M Miller; Shannon G Matta; Elissa J Chesler; Dan Goldowitz; Charles D Blaha; Guy Mittleman
Journal:  Psychopharmacology (Berl)       Date:  2011-01-07       Impact factor: 4.530

5.  Muscarinic type 2 receptors in the lateral dorsal tegmental area modulate cocaine and food seeking behavior in rats.

Authors:  S Shabani; R Foster; N Gubner; T J Phillips; G P Mark
Journal:  Neuroscience       Date:  2010-07-24       Impact factor: 3.590

6.  Separating analgesia from reward within the ventral tegmental area.

Authors:  E Schifirneţ; S E Bowen; G S Borszcz
Journal:  Neuroscience       Date:  2014-01-13       Impact factor: 3.590

7.  Sonic hedgehog maintains cellular and neurochemical homeostasis in the adult nigrostriatal circuit.

Authors:  Luis E Gonzalez-Reyes; Miguel Verbitsky; Javier Blesa; Vernice Jackson-Lewis; Daniel Paredes; Karsten Tillack; Sudarshan Phani; Edgar R Kramer; Serge Przedborski; Andreas H Kottmann
Journal:  Neuron       Date:  2012-07-26       Impact factor: 17.173

8.  Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.

Authors:  Guangrong Zheng; Andrew M Smith; Xiaoqin Huang; Karunai L Subramanian; Kiran B Siripurapu; Agripina Deaciuc; Chang-Guo Zhan; Linda P Dwoskin
Journal:  J Med Chem       Date:  2013-02-18       Impact factor: 7.446

9.  Somatodendritic targeting of M5 muscarinic receptor in the rat ventral tegmental area: implications for mesolimbic dopamine transmission.

Authors:  Miguel Garzón; Virginia M Pickel
Journal:  J Comp Neurol       Date:  2013-09-01       Impact factor: 3.215

10.  Discovery, synthesis and characterization of a highly muscarinic acetylcholine receptor (mAChR)-selective M5-orthosteric antagonist, VU0488130 (ML381): a novel molecular probe.

Authors:  Patrick R Gentry; Masaya Kokubo; Thomas M Bridges; Hyekyung P Cho; Emery Smith; Peter Chase; Peter S Hodder; Thomas J Utley; Anuruddha Rajapakse; Frank Byers; Colleen M Niswender; Ryan D Morrison; J Scott Daniels; Michael R Wood; P Jeffrey Conn; Craig W Lindsley
Journal:  ChemMedChem       Date:  2014-04-01       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.